以双特异性抗体 XmAb 18968 靶向 CD38 治疗复发/难治性急性髓系白血病和 T 细胞急性淋巴细胞白血病患者
Targeting CD38 with bispecific antibody XmAb 18968 in patients with relapsed/refractory acute myeloid leukemia and T-cell acute lymphoblastic leukemia
82.5分
★★★★☆
站内排序·非疗效
ALL SOURCES
Targeting CD38 with bispecific antibody XmAb 18968 in patients with relapsed/refractory acute myeloid leukemia and T-cell acute lymphoblastic leukemia
Where do immunotherapies stand in management of acute leukemia in adults?
共 2 条
MEMBER ACCOUNT
登录成功会直接打开下一页。